3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
4
Tumor-Agnostic
3
Gastrointestinal
3
Breast
3
Other hematologic neoplasm
2
Plasma cell
1
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma
1
Leukemia
1
Interventions
Cyclophosphamide
78
Rituximab
61
Specimen Handling
49
Doxorubicin
42
Biopsy
42
Vincristine
41
Magnetic Resonance Spectroscopy
39
Prednisone
37
fludarabine
29
venetoclax
28
obinutuzumab
27
Methotrexate
23
ibrutinib
22
Lenalidomide
21
Dexamethasone
21
Cytarabine
21
blinatumomab
19
Etoposide
19
zanubrutinib
18
merphos
17
fludarabine phosphate
17
acalabrutinib
17
prednylidene
15
deltacortene
15
X-Rays
14
Mercaptopurine
14
CT-P10
14
Bendamustine Hydrochloride
14
pegaspargase
13
Calcium Dobesilate
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Exercise
×
Lymphoid
×
30 days
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled